The past, present and future of AAV vectors
Nathalie Clement, PhD, Unicorn Consultations, Gainesville, FL, provides an overview of her experiences working with adeno-associated viral (AAV) vectors, from its infancy of the field to the present day, where clinical trials are being conducted to assess AAV-based therapies. Dr Clement additionally highlights the growth of the AAV vector field and the increased demand for treatments, as well as the history of AAV vector research. This interview took place at Advanced Therapies Week 2022.
Видео The past, present and future of AAV vectors канала VJRegenMed
Видео The past, present and future of AAV vectors канала VJRegenMed
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![CAR-T trials to watch in China](https://i.ytimg.com/vi/g-dN3U2Ht9U/default.jpg)
![Exploring the potential role of CD7-targeting CAR-T cells in T-ALL](https://i.ytimg.com/vi/YlMw43TyJHQ/default.jpg)
![Current developments in cell therapies for solid tumors](https://i.ytimg.com/vi/QITTCJh9Fvo/default.jpg)
![Tabelecleucel in EBV-associated PTLD](https://i.ytimg.com/vi/8JcXIlfI-q8/default.jpg)
![Challenges in decentralized manufacturing systems](https://i.ytimg.com/vi/T3PBj8gYXH8/default.jpg)
![PiggyBac Transposon-generated CAR T-cells in solid tumors](https://i.ytimg.com/vi/UZ1FNxol_EM/default.jpg)
![Nerve regeneration with polyhydroxyalkanoate-based conduits](https://i.ytimg.com/vi/5Iv5tFCWmt0/default.jpg)
![LUMEVOQ gene therapy for LHON](https://i.ytimg.com/vi/ZICV7g0pPno/default.jpg)
![Harnessing lipid-specific TCRs to target CD1c-expressing leukemia](https://i.ytimg.com/vi/WH1CmN9pOtw/default.jpg)
![EV-based therapies for myocardial infarction](https://i.ytimg.com/vi/xmCwbtvybxo/default.jpg)
![Plasmacytoid dendritic cell-based cancer vaccines](https://i.ytimg.com/vi/iOzC5GkNcxQ/default.jpg)
![Paige Bischoff, Senior VP, Public Affairs, Alliance for Regenerative Medicine](https://i.ytimg.com/vi/x34AXUWTAZI/default.jpg)
![The changing landscape of hospital-based cell and gene therapy manufacturing](https://i.ytimg.com/vi/ewPHBOWF2ME/default.jpg)
![Increasing manufacturing capabilities for gene therapies](https://i.ytimg.com/vi/cdzjk2TvcIQ/default.jpg)
![Developing gene therapies for GJB2 gene related hearing loss](https://i.ytimg.com/vi/ZkRtcwnfNvs/default.jpg)
![Progression of CAR-T trials in China](https://i.ytimg.com/vi/__VdZLVS0bA/default.jpg)
![Addressing supply chain issues in clinical trials](https://i.ytimg.com/vi/Ha3wm2ZfevE/default.jpg)
![IL-1Ra gene therapy for knee OA: interim Phase I results](https://i.ytimg.com/vi/sGl5q1-EvUM/default.jpg)
![Enhancing AAV gene therapy in children with inborn errors of metabolism](https://i.ytimg.com/vi/XJEA-vlmwIM/default.jpg)
![SPEARHEAD-1: ADP-A2M4 in synovial sarcoma and MRCLS](https://i.ytimg.com/vi/adXUZr--4ok/default.jpg)